See more : Killam Apartment REIT (KMMPF) Income Statement Analysis – Financial Results
Complete financial analysis of Itamar Medical Ltd. (ITMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Itamar Medical Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- ClearVue Technologies Limited (CPV.AX) Income Statement Analysis – Financial Results
- Minehub Technologies Inc. (MHUBF) Income Statement Analysis – Financial Results
- The Descartes Systems Group Inc. (DSGX) Income Statement Analysis – Financial Results
- HYUNDAI WIA Corporation (011210.KS) Income Statement Analysis – Financial Results
- Public Power Corporation S.A. (PPC.AT) Income Statement Analysis – Financial Results
Itamar Medical Ltd. (ITMR)
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.03M | 31.26M | 24.19M | 20.70M | 18.44M | 16.81M | 16.39M | 13.34M | 13.43M |
| Cost of Revenue | 12.32M | 6.98M | 5.73M | 5.00M | 4.98M | 4.40M | 4.80M | 4.26M | 3.80M |
| Gross Profit | 28.71M | 24.27M | 18.46M | 15.70M | 13.46M | 12.41M | 11.59M | 9.08M | 9.62M |
| Gross Profit Ratio | 69.97% | 77.66% | 76.33% | 75.84% | 73.00% | 73.81% | 70.72% | 68.07% | 71.68% |
| Research & Development | 6.00M | 4.52M | 3.64M | 4.13M | 3.23M | 2.83M | 2.02M | 1.89M | 1.69M |
| General & Administrative | 8.50M | 6.35M | 5.25M | 5.28M | 5.36M | 4.30M | 4.63M | 4.88M | 2.55M |
| Selling & Marketing | 24.55M | 18.29M | 12.70M | 12.14M | 14.04M | 10.68M | 8.44M | 7.40M | 5.69M |
| SG&A | 33.05M | 24.65M | 17.95M | 17.42M | 19.40M | 14.98M | 13.07M | 12.28M | 8.23M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 849.00K | 52.00K | 113.00K | 117.00K | 217.00K |
| Operating Expenses | 39.06M | 29.17M | 21.58M | 21.55M | 23.47M | 17.87M | 15.20M | 14.29M | 10.14M |
| Cost & Expenses | 51.38M | 36.15M | 27.31M | 26.55M | 28.45M | 22.27M | 20.00M | 18.54M | 13.94M |
| Interest Income | 713.00K | 454.00K | 93.00K | 1.39M | 547.00K | 176.00K | -571.00K | 714.00K | 121.00K |
| Interest Expense | 562.00K | 284.00K | 794.00K | 4.43M | 4.61M | 4.19M | 2.51M | 4.83M | 2.12M |
| Depreciation & Amortization | 1.82M | 1.29M | 481.00K | 509.00K | 434.00K | 367.00K | 324.00K | 400.00K | 330.00K |
| EBITDA | -8.43M | -3.66M | -330.00K | -280.00K | -9.23M | 2.44M | -313.00K | -7.73M | 2.76M |
| EBITDA Ratio | -20.55% | -11.71% | -1.36% | -1.35% | -50.04% | 14.53% | -1.91% | -57.95% | 20.57% |
| Operating Income | -10.34M | -4.89M | -3.12M | -5.85M | -10.01M | -5.46M | -3.61M | -5.21M | -515.00K |
| Operating Income Ratio | -25.21% | -15.66% | -12.90% | -28.25% | -54.30% | -32.48% | -22.02% | -39.04% | -3.84% |
| Total Other Income/Expenses | -468.00K | -337.00K | 1.52M | 632.00K | -4.26M | 3.35M | 458.00K | -7.76M | 831.00K |
| Income Before Tax | -10.81M | -5.23M | -1.61M | -5.22M | -14.27M | -2.11M | -3.15M | -12.96M | 316.00K |
| Income Before Tax Ratio | -26.35% | -16.73% | -6.64% | -25.20% | -77.40% | -12.57% | -19.23% | -97.20% | 2.35% |
| Income Tax Expense | 127.00K | 37.00K | 124.00K | 85.00K | 131.00K | 135.00K | 124.00K | -44.00K | -201.00K |
| Net Income | -10.94M | -5.27M | -1.73M | -5.30M | -14.40M | -2.25M | -3.28M | -12.92M | 517.00K |
| Net Income Ratio | -26.66% | -16.85% | -7.15% | -25.61% | -78.11% | -13.37% | -19.99% | -96.87% | 3.85% |
| EPS | -0.79 | -0.46 | -0.17 | -0.60 | -1.65 | -0.35 | -0.56 | -2.82 | 0.03 |
| EPS Diluted | -0.79 | -0.46 | -0.17 | -0.52 | -1.65 | -0.29 | -0.46 | -2.82 | 0.03 |
| Weighted Avg Shares Out | 13.85M | 11.54M | 10.13M | 8.80M | 8.75M | 6.39M | 5.83M | 4.58M | 16.42M |
| Weighted Avg Shares Out (Dil) | 13.85M | 11.54M | 10.13M | 10.13M | 8.75M | 7.73M | 7.15M | 4.58M | 16.42M |
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q2 Loss, Tops Revenue Estimates
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 3.33% and 3.97%, respectively, for the quarter ended June 2021.
Itamar Medical: Q2 Earnings Insights
Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share decreased 17.65% year over year to ($0.20), which beat the estimate of ($0.29).
Itamar Medical Reports Second Quarter 2021 Financial Results
- Revenues Increased 41% Year-over-Year to $12.6 Million -
Earnings Preview: Itamar Medical Ltd. Sponsored ADR (ITMR) Q2 Earnings Expected to Decline
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Itamar Medical to Report Second Quarter Financial Results and Host Conference Call on Tuesday, August 10, 2021
CAESAREA, Israel, July 28, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that...
Itamar Medical to Present at the Ladenburg Thalmann Annual Healthcare Conference on Wednesday, July 14, 2021
CAESAREA, Israel, June 30, 2021 (GLOBE NEWSWIRE) -- ItamarTM Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the...
Itamar Medical Launches Enhancements to WatchPAT™ Product Line at SLEEP 2021
Enables Patient Smartphone App to Collect Subjective Data at Time of Test
Itamar Medical Appoints Brad Fluegel to its Board of Directors
CAESAREA, Israel, May 24, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the...
Itamar Medical Ltd. Sponsored ADR (ITMR) Moves 6.5% Higher: Will This Strength Last?
Itamar Medical Ltd. Sponsored ADR (ITMR) saw its shares surge in the last session with trading volume being higher than average.
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q1 2021 Results - Earnings Call Transcript
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q1 2021 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports